Form 8.3 ADVANCED MEDICAL SOLUTIONS GROUP PLC

Summary by AI BETAClose X

Barclays disclosed an open position in Advanced Medical Solutions Group PLC comprising 7,684,527 ordinary shares (3.48% of issued share capital) directly owned/controlled and short positions of 895,738 shares (0.41%), with aggregate positions reported as 8,579,629 shares (3.88%). On 11 Nov 2026 Barclays executed purchases totaling 189,376 shares at c. £2.825–£2.8325 and sales totaling 105,843 shares at c. £2.825–£2.8283, yielding a net on-market purchase of 83,533 shares. Barclays also reports cash-settled derivative exposures including 895,102 units (0.41%) and 7,684,526 units (3.48%) and stated no indemnity or related arrangements.

Disclaimer*

UK 100